Sicca/Sjogren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR)


Ramos-Casals M., Maria A., Suarez-Almazor M. E. , Lambotte O., Fisher B. A. , Hernandez-Molina G., ...More

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, vol.37, no.3, 2019 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 37 Issue: 3
  • Publication Date: 2019
  • Journal Name: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
  • Journal Indexes: Science Citation Index Expanded, Scopus

Abstract

Objectives: To analyse the worldwide occurrence of sicca/Sjogren's (SS) syndrome associated with the use of immune checkpoint inhibitors (ICI) in patients with cancer.